HUE048496T2 - Kroszpovidont tartalmazó tabletta - Google Patents
Kroszpovidont tartalmazó tablettaInfo
- Publication number
- HUE048496T2 HUE048496T2 HUE14766730A HUE14766730A HUE048496T2 HU E048496 T2 HUE048496 T2 HU E048496T2 HU E14766730 A HUE14766730 A HU E14766730A HU E14766730 A HUE14766730 A HU E14766730A HU E048496 T2 HUE048496 T2 HU E048496T2
- Authority
- HU
- Hungary
- Prior art keywords
- crospovidone
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13185368 | 2013-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE048496T2 true HUE048496T2 (hu) | 2020-07-28 |
Family
ID=49223642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14766730A HUE048496T2 (hu) | 2013-09-20 | 2014-09-18 | Kroszpovidont tartalmazó tabletta |
Country Status (11)
Country | Link |
---|---|
US (1) | US10159647B2 (hu) |
EP (1) | EP3046548B1 (hu) |
CN (1) | CN105555261B (hu) |
DK (1) | DK3046548T3 (hu) |
ES (1) | ES2780874T3 (hu) |
HU (1) | HUE048496T2 (hu) |
PL (1) | PL3046548T3 (hu) |
PT (1) | PT3046548T (hu) |
RS (1) | RS60054B1 (hu) |
SI (1) | SI3046548T1 (hu) |
WO (1) | WO2015040093A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
WO2022017864A1 (en) * | 2020-07-24 | 2022-01-27 | Dsm Ip Assets B.V. | New fast dissolvable tablets |
CN113274357B (zh) * | 2021-05-28 | 2022-12-27 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种阿莫西林药物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9200139A (en) | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
CN1194687C (zh) * | 1997-02-14 | 2005-03-30 | 史密斯克莱恩比彻姆药物实验室 | 含有阿莫西林和克拉维酸盐的药物制剂 |
US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
US6878386B1 (en) * | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US20020006433A1 (en) | 1999-04-29 | 2002-01-17 | Nigel P. Davidson | Pharmaceutical formulations |
-
2014
- 2014-09-18 HU HUE14766730A patent/HUE048496T2/hu unknown
- 2014-09-18 ES ES14766730T patent/ES2780874T3/es active Active
- 2014-09-18 SI SI201431515T patent/SI3046548T1/sl unknown
- 2014-09-18 RS RS20200214A patent/RS60054B1/sr unknown
- 2014-09-18 US US14/916,613 patent/US10159647B2/en active Active
- 2014-09-18 DK DK14766730.7T patent/DK3046548T3/da active
- 2014-09-18 PT PT147667307T patent/PT3046548T/pt unknown
- 2014-09-18 CN CN201480051679.5A patent/CN105555261B/zh active Active
- 2014-09-18 EP EP14766730.7A patent/EP3046548B1/en active Active
- 2014-09-18 WO PCT/EP2014/069852 patent/WO2015040093A1/en active Application Filing
- 2014-09-18 PL PL14766730T patent/PL3046548T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
CN105555261B (zh) | 2020-02-11 |
SI3046548T1 (sl) | 2020-04-30 |
PT3046548T (pt) | 2020-03-04 |
US20160193153A1 (en) | 2016-07-07 |
CN105555261A (zh) | 2016-05-04 |
EP3046548A1 (en) | 2016-07-27 |
ES2780874T3 (es) | 2020-08-27 |
EP3046548B1 (en) | 2020-02-12 |
RS60054B1 (sr) | 2020-04-30 |
PL3046548T3 (pl) | 2020-07-13 |
DK3046548T3 (da) | 2020-04-27 |
WO2015040093A1 (en) | 2015-03-26 |
US10159647B2 (en) | 2018-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219663A1 (zh) | 藥物組合 | |
GB201306312D0 (en) | Tablet case | |
HRP20180684T1 (hr) | Kombinacija lijekova | |
GB201322602D0 (en) | Pharmaceutical compounds | |
GB201302901D0 (en) | Ubuntu tablet | |
GB201306610D0 (en) | Pharmaceutical compounds | |
ZA201602047B (en) | Pharmaceutical compounds | |
IL241350A0 (en) | Subprevir tablets | |
HK1205463A1 (zh) | 含有 -羥基- -咪唑- -甲酰胺的片劑 | |
GB201312386D0 (en) | Pharmaceutical compounds | |
PL3046548T3 (pl) | Tabletka zawierająca krospowidon | |
EP3069714A4 (en) | Tablet | |
GB201316662D0 (en) | Pharmaceutical Combination | |
GB201317166D0 (en) | Pharmaceutical compounds | |
GB201316780D0 (en) | Pharmaceutical compounds | |
GB201316791D0 (en) | Pharmaceutical Compounds | |
GB201315733D0 (en) | Pharmaceutical compounds | |
GB201315734D0 (en) | Pharmaceutical compounds | |
GB201312464D0 (en) | Pharmaceutical compounds | |
GB201308780D0 (en) | Pharmaceutical compounds | |
GB201308781D0 (en) | Pharmaceutical compounds | |
GB201308782D0 (en) | Pharmaceutical compounds | |
GB201310496D0 (en) | Pharmaceutical combinations | |
GB201301723D0 (en) | Pharmaceutical combinations |